insights_auto
Why is GALT up 3,72%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
3,90 $
arrow_upward
+3,72%(+0,14) 1D
3,87 $
arrow_downward
-0,85% (-0,033)bedtimeAfter hours
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
3,82 $
High
3,94 $
Low
3,75 $
Mkt. cap
393,31 մլն
Avg. vol.
304,26 հզր
Volume
220,31 հզր
52-wk high
7,13 $
52-wk low
2,02 $
EPS
-0,43 $
Beta
0,38
Shares outstanding
100,85 մլն
No. of employees
9
Open
3,82 $
High
3,94 $
Low
3,75 $
Mkt. cap
393,31 մլն
Avg. vol.
304,26 հզր
Volume
220,31 հզր
52-wk high
7,13 $
52-wk low
2,02 $
EPS
-0,43 $
Beta
0,38
Shares outstanding
100,85 մլն
No. of employees
9
News stories
From web sources and news partners
Business Wire
·
50 րոպե առաջ
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall Street
·
22 րոպե առաջ
Halozyme Therapeutics (HALO) Brings Jim Daly Back To Its Board As Launch Focus Sharpens
MarketBeat
·
36 րոպե առաջ
PTC Therapeutics (NASDAQ:PTCT) Director Sells $781,920.00 in Stock
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Ջորջիա, Միացյալ Նահանգներ
Sector-
Websitegalectintherapeutics.com